Target Price | HKD25.60 |
Price | HKD28.95 |
Deviation |
11.56%
register free of charge
|
Number of Estimates | 16 |
16 Analysts have issued a price target Henderson Land Development 2026 .
The average Henderson Land Development target price is HKD25.60.
This is
11.56%
register free of charge
HKD32.55
12.44%
register free of charge
HKD19.19
33.71%
register free of charge
|
|
A rating was issued by 22 analysts: 15 Analysts recommend Henderson Land Development to buy, 6 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Henderson Land Development stock has an average upside potential 2026 of
11.56%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion HKD | 25.26 | 28.99 |
8.39% | 14.79% | |
EBITDA Margin | 22.17% | 32.09% |
39.47% | 44.73% | |
Net Margin | 24.93% | 30.92% |
25.79% | 24.03% |
18 Analysts have issued a sales forecast Henderson Land Development 2025 . The average Henderson Land Development sales estimate is
This results in the following potential growth metrics:
17 Henderson Land Development Analysts have issued a net profit forecast 2025. The average Henderson Land Development net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share HKD | 1.30 | 1.85 |
31.94% | 42.31% | |
P/E | 15.63 | |
EV/Sales | 9.48 |
17 Analysts have issued a Henderson Land Development forecast for earnings per share. The average Henderson Land Development EPS is
This results in the following potential growth metrics and future valuations:
Henderson Land Development...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.